Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation Publisher Pubmed



Kararoudi MN1 ; Hejazi SS2 ; Elmas E1 ; Hellstrom M3 ; Kararoudi MN1 ; Padma AM3 ; Lee D1 ; Dolatshad H5
Authors
Show Affiliations
Authors Affiliations
  1. 1. The Childhood Cancer Center, Nationwide Children's Hospital, Columbus, OH, United States
  2. 2. Department of Basic Science of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran
  3. 3. Laboratory for Transplantation and Regenerative Medicine, Department of Obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  4. 4. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Science, Tehran, Iran
  5. 5. Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

Source: Frontiers in Immunology Published:2018


Abstract

Genetically modified pigs have been considered favorable resources in xenotransplantation. Microinjection of randomly integrating transgenes into zygotes, somatic cell nuclear transfer, homologous recombination, zinc finger nucleases, transcription activator-like effector nucleases, and most recently, clustered regularly interspaced short palindromic repeats-cas9 (CRISPR/Cas9) are the techniques that have been used to generate these animals. Here, we provide an overview of the CRISPR approaches that have been used to modify genes which are vital in improving xenograft survival rate, including cytidine monophosphate-N-acetylneuraminic acid hydroxylase, B1,4N-acetylgalactosaminyltransferase, isoglobotrihexosylceramide synthase, class I MHC, von Willebrand factor, C3, and porcine endogenous retroviruses. In addition, we will mention the importance of potential candidate genes which could be targeted using CRISPR/Cas9. © 2018 Naeimi Kararoudi, Hejazi, Elmas, Hellstrom, Naeimi Kararoudi, Padma, Lee and Dolatshad.